Hyper-CVAD + epratuzumab as a salvage regimen for younger patients with relapsed/refractory CD22-positive precursor B-cell acute lymphocytic leukemia
暂无分享,去创建一个
H. Dombret | P. Chevallier | M. Béné | X. Thomas | D. Goldenberg | N. Robillard | E. Raffoux | W. Wegener | S. Maury | F. Huguet | A. Charbonnier | F. Rialland | T. Guillaume | T. Leguay | P. Peterlin | F. Isnard | T. Marchand | M. Gallego-Hernanz | S. Chantepie | A. Garnier | C. Le Houérou | William A. Wegener